Nissim Darvish SEC EDGAR Filings (CIK 0001793602)

SEC EDGAR filings, ownership reports, and insider transactions for Nissim Darvish.

Business address
C/O Innovate Biopharmaceuticals, Inc., 8480 Honeycutt Road, Suite 120, Raleigh, NC, 27615
Top holdings (ownership)
CMMB
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Nissim Darvish has filed 12 SEC EDGAR filings since 04 May 2020

Latest Filings

Recent SEC filings for Nissim Darvish including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 05 Jul 2023 14 Jun 2023 001-38807
4 Open 4 document View SEC filing for 4 23 Mar 2023 16 Mar 2023 001-38807
4 Open 4 document View SEC filing for 4 14 Mar 2022 11 Mar 2022 001-38807
4 Open 4 document View SEC filing for 4 09 Mar 2022 07 Mar 2022 001-38807
4 Open 4 document View SEC filing for 4 FORM 4 21 Apr 2021 19 Apr 2021 001-38807
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Mar 2021 16 Mar 2021 001-38807
4 Open 4 document View SEC filing for 4 FORM 4 03 Nov 2020 30 Oct 2020 001-37797
4 Open 4 document View SEC filing for 4 FORM 4 08 Jul 2020 06 Jul 2020 001-37797
4 Open 4 document View SEC filing for 4 FORM 4 02 Jul 2020 30 Jun 2020 001-37797
4 Open 4 document View SEC filing for 4 FORM 4 05 May 2020 04 May 2020 001-37797
4 Open 4 document View SEC filing for 4 FORM 4 04 May 2020 30 Apr 2020 001-37797
3 Open 3 document View SEC filing for 3 FORM 3 04 May 2020 30 Apr 2020 001-37797

About this filer

Nissim Darvish files with the SEC under CIK 0001793602. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages